This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.
In this discussion, you’ll learn:
From the Spreadsheet Age to the Age of Generative AI: Where is your organization on the continuum of Insights Management? (And why no one “age” fits the needs of all teams.)
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches. Learn from industry experts about the strategic goals of Medical Affairs and its unique impact generation in a cross-functional environment. Discover essential metrics for assessing performance and best practices for implementation. Explore cutting-edge data generation methods and technological advancements to enhance data quality and impact measurement.
Key topics to be addressed include:
What is the strategic goal of Medical Affairs and how does it generate impact?
What are the key metrics to measure Medical Affairs’ performance and impact?
How can innovative data approaches enhance measuring Medical Affairs’ impact?
The Medical Affairs Professional Society (MAPS) Insights Focus Area Working Group (FAWG) formed a subcommittee to identify best practices and recommend guidelines for an effective insights management process. The following slides are an overview of key success factors identified.
This white paper addresses insights challenges in Strategy, Data Generation, and Analysis/Reporting – arming Medical Affairs teams with the tools and opportunity to build strategies that preempt these challenges.
Advisory boards bring together a selection of key opinion leaders to discuss a topic important to a life sciences company. Here is how to use engagement technologies to generate actionable insights from your next ad board.
With the vast amount of data available today, Medical Affairs organizations are tasked with continuously enhancing their ability to gather, analyze and derive insights from various data sources. Information is compounding at an increasingly faster pace and, if harnessed effectively, can allow Medical Affairs executives to make insight-driven decisions that drive company-wide strategy. This presentation will focus on:
This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.